Prescription Pricing for the People Act of 2019 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Business ethicsBusiness recordsCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale trades
Prescription Pricing for the People Act of 2019
USA116th CongressS-1227| Senate
| Updated: 6/28/2019
Prescription Pricing for the People Act of 2019 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Business ethicsBusiness recordsCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale trades